Atlas Trials

A Study Evaluating AL-3778 in Combination With Peginterferon Alpha-2a in Chronic Hepatitis B Subjects

Clinical trial NCT03125213 · WITHDRAWN

Trial details

NCT number
NCT03125213
Sponsor
Alios Biopharma Inc.
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis B, Chronic
Start date
2017-09-12
Primary completion
2019-02-15
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.